Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif.
Location: United States, California, Seal Beach
Member count: 501-1000
Founded date: 1992
Investors 3
| Date | Name | Website |
| - | Alliance of An... | allianceofange... |
| - | Rho Ventures | rhoventures.co... |
| - | Rho Capital Pa... | rho.com |
Mentions in press and media 25
| Date | Title | Description | Source |
| 15.05.2019 | With new c... | “It’s something that we’ve always struggled with,” Tada said in a phone interview, referring to the ... | medcitynew... |
| 09.05.2019 | Don’t miss... | A panel discussion will explore how precision medicine can be the key to population health. Experts ... | medcitynew... |
| 05.02.2015 | Former Den... | Dendreon is known for launching Provenge, a prostate cancer drug that was the first-ever immunothera... | medcitynew... |
| 07.03.2012 | No IPO for... | But the public markets have remained cool to life science IPOs. Merrimack Pharmaceuticals, a a Cambr... | medcitynew... |
| 16.02.2012 | Life scien... | Heat Bio. Heat’s lead drug program is an experimental lung cancer treatment in phase 2 clinical tria... | medcitynew... |
| 08.09.2011 | Dendreon W... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints [Updated: 1:15 pm PT] People at Se... | xconomy.co... |
| 07.09.2011 | Provenge f... | The impact of slow sales of Dendreon‘s (NASDAQ:DNDN) prostate cancer treatment Provenge is reaching ... | medcitynew... |
| 29.07.2011 | What Argos... | Proceeds from the stock offering will be used to finance trials that will test lead product candidat... | medcitynew... |
| 13.05.2011 | Immunother... | Immunotherapy induces a patient’s own immune system to fight disease. Argo’s technology, called Arce... | medcitynew... |
| 27.04.2010 | Morning Re... | Highlights of the important and the interesting from the world of healthcare: The case for private-... | medcitynew... |
Show more